Skip to content
Recall Observatory FDA recall evidence

Drug product

Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

D-1032-2020

March 13, 2020

Class II

Product summary

Firm
Sun Pharmaceutical Industries, Inc.
Event
Event 85230
Status
Terminated
Classification
Class II
Quantity
624 bottles
Official record key
drug-enforcement:D-1032-2020

Official wording

Reason: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Code information: Lot #: AA39490, Exp 03/2021

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations